Recent 13F filings as of December 2025 show that 160 institutional investors hold a position in Theravance Biopharma, Inc. (NASDAQ:TBPH).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Madison Avenue Partners, LP | 31 Dec, 2025 | 9,511,150 | 0 | 0.00% | $177,953,617.00 |
| Weiss Asset Management LP | 31 Dec, 2025 | 7,457,060 | 0 | 0.00% | $139,521,593.00 |
| Newtyn Management, LLC | 31 Dec, 2025 | 4,300,000 | -650,000 | -13.13% | $80,453,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,050,525 | -18,469 | -0.45% | $75,785,323.00 |
| Irenic Capital Management LP | 31 Dec, 2025 | 2,760,948 | 0 | 0.00% | $51,657,337.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,367,353 | 155,771 | 7.04% | $44,293,175.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 1,259,941 | 50,629 | 4.19% | $23,573,496.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 1,165,959 | 76,578 | 7.03% | $21,806.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,101,892 | 45,987 | 4.36% | $20,616,399.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 963,257 | 236,474 | 32.54% | $18,022,538.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 938,724 | 40,734 | 4.54% | $17,566,969.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 858,957 | 92,253 | 12.03% | $16,071,946.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 803,118 | 203,567 | 33.95% | $15,026,338.00 |
| Oasis Management Co Ltd. | 31 Dec, 2025 | 727,161 | -391,774 | -35.01% | $13,605,182.00 |
| UBS Group AG | 31 Dec, 2025 | 570,425 | 56,255 | 10.94% | $10,672,651.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 537,341 | 306,069 | 132.34% | $10,053,650.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 473,498 | 262,450 | 124.36% | $8,859,148.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 418,629 | 60,978 | 17.05% | $7,832,548.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 416,408 | 203,304 | 95.40% | $7,790,992.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 404,144 | -10,571 | -2.55% | $7,561,534.00 |